/

EvolveImmune Therapeutics

Developing next-generation T cell engagers for cancer immunotherapy.

BiotechnologyPharmaceuticals evolveimmune.com ↗

Company facts

Founded: 2020
Employees: 53
Headquarters: United States
Type: Private
Funding: Corporate Round · $65M · 2024